News Chart BioVaxys Technology Corp.

Equities

BIOV

CA09076M1014

Delayed Canadian Securities Exchange Other stock markets 20:35:54 15/05/2024 BST			5-day change	1st Jan Change
0.07 ^CAD	-12.50%		-.--%	+40.00%

05-02	Biovaxys Technology Corp. Delays to File Its Interim Financial Statements for the Three Months Ended January 31, 2024	CI
04-30	BioVaxys Technology Corp. Appoints Christopher Cherry as Chief Financial Officer	CI

6a720b76d3b19a094.sOumSKSOQ_uIMFCEMH4Ys3oAyoLhlXWWLEp-d5bzBis.9KfPAePIdpL7HWTVQQ5o6hhur7XU_xTveCAsEeK5XnLviPcG0f8ngfpyBQ~c7132f09c6d14827669be40286f939d3